首页|Clinically and orally compatible formulation-manufactured DDX5(p68)-targeting molecular glue FL118 products exhibit low toxicity but high efficacy against human cancer

Clinically and orally compatible formulation-manufactured DDX5(p68)-targeting molecular glue FL118 products exhibit low toxicity but high efficacy against human cancer

扫码查看

Xiang Ling、Wenjie Wu、Li Yan、Leslie Curtin、Melanie M.Farrauto、Sandra Sexton、Anmbreen Jamroze、Changjun Yu、Christos Fountzilas、Dean G.Tang、Fengzhi Li

展开 >

Department of Pharmacology & Therapeutics,Roswell Park Comprehensive Cancer Center,Buffalo,New York,14263,USA

Canget BioTekpharma LLC,Buffalo,New York,14203,USA

Department of Biostatistics & Bioinformatics,Roswell Park Comprehensive Cancer Center Buffalo,New York,14263,USA

Comparative Oncology Shared Resources,Roswell Park Comprehensive Cancer Center,Buffalo,New York,14263,USA

California Institute of Technology,Pasadena,CA,91125,USA

Department of Medicine,Roswell Park Comprehensive Cancer Center,Buffalo,New York,14263,USA

Developmental Therapeutics(DT)Program,Roswell Park Comprehensive Cancer Center,Buffalo,New York,14263,USA

Pancreatic Cancer Research Center,Roswell Park Comprehensive Cancer Center,Buffalo,New York,14263,USA

Genitourinary(GU)Oncology Research Center,Roswell Park Comprehensive Cancer Center,Buffalo,New York,14263,USA

展开 >

2024

药物分析学报(英文)
西安交通大学

药物分析学报(英文)

影响因子:0.244
ISSN:2095-1779
年,卷(期):2024.14(11)